Consistently with this hypothesis, deletion of DHODH in tumor cells with fully functional OXPHOS suppressed tumor development, while suppression of mitochondrial ATP synthase produced minimal effects [26], thus implicating DHODH as a potential therapeutic target for OXPHOS-dependent cancers. This evidence concerns the gene DHODH and cancer.